1. Yan Ma , Kun Shang , Shanshan Wu , Jing Wang , Bangwei Cao.The Prognostic Value of Albumin-Globulin Ratio and Eosinophil-Neutrophil Ratio in Patients with Advanced Tumors Undergoing Treatment with PD-1/PD-L1 Inhibitors..Nutr Cancer. .2022. Feb 1. 1–14 doi: 10.1080/01635581.SCI |
2. Zhao P, Zhen H, Zhao H, Zhao L, Cao B#.Efficacy and safety of adjuvant EGFR-TKIs for resected non-small cell lung cancer: a systematic review and meta-analysis based on randomized control trials.BMC Cancer..2022.26;22(1).328.SCI |
3. Tian JZ, Ma NN, Li X, Shang K, Cao BW*..Drug therapy for bone metastasis of malignant tumor: theory, progress, and potential..Neoplasma.2022.69(3).504-515.SCI |
4. Yan Ma 1 2, Xiao Ma 2, Jingting Wang 2, Shanshan Wu 3, Jing Wang 4, Bangwei Cao *.Absolute eosinophil count may be an optimal peripheral blood marker to identify the risk of immune-related adverse events in advanced malignant tumors treated with PD-1/PD-L1 inhibitors: a retrospective analysis..World J Surg Oncol.2022.20(1).242. doi: 10.1186/s12957-022-02695-y.SCI |
5. Lin H, Cao B*..Alteration in the Immune Microenvironment Based on APC Status in MSS/pMMR Colon Cancer..Dis Markers.2022.2022:3592990.3592990. doi: 10.1155/2022/3592990.SCI |
6. Zheng X, Liu J, Li X, Tian R, Shang K, Dong X, Cao B*. . Angiogenesis is promoted by exosomal DPP4 derived from 5-fluorouracil-resistant colon cancer cells.Cancer Lett. .2021.28;497:.190-201.SCI |
7. Ma Y, Wang J, Li Q, Cao B*. .The Effect of Omega-3 Polyunsaturated Fatty Acid Supplementations on anti-Tumor Drugs in Triple Negative Breast Cancer..Nutr Cancer.2021.3(2):.196-205. .SCI |
8. Jingting Wang , Xiao Ma , Hai Si , Zhongjun Ma , Yan Ma , Jing Wang , Bangwei Cao.Role of long non-coding RNA H19 in therapy resistance of digestive system cancers..Mol Med.2021.5;27(1).(1)-(9).SCI |
9. Jiexuan Hu , Ruyue Tian , Yingjie Ma , Hongchao Zhen , Xiao Ma , Qiang Su , Bangwei Cao .Risk of Cardiac Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Regimens: A Systematic Review and Meta-Analysis.Front Oncol.2021.27;11.645245.SCI |
10. Ma Y, Wang J, Li Q, Cao B*..The Effect of Omega-3 Polyunsaturated Fatty Acid Supplementations on anti-Tumor Drugs in Triple Negative Breast Cancer..Nutr Cancer..2021.73(2).196-205.SCI |
11. Ma Y, Yu J, Li Q, Su Q, Cao Bangwei*.Addition of docosahexaenoic acid synergistically enhances the efficacy of apatinib for triple-negative breast cancer therapy..Biosci Biotechnol Biochem..2020.84(4).743-756.SCI |
12. Wang J, Zhao L, Shang K, Liu F, Che J, Li H, Cao B*..Long non-coding RNA H19, a novel therapeutic target for pancreatic cancer..Mol Med..2020. 9;26(1).30.SCI |
13. Zhang N, Ren Y, Wang Y, Zhao L, Wang B, Ma N, Gao Z, Cao Bangwei*.LRG1 Suppresses Migration and Invasion of Esophageal Squamous Cell Carcinoma by Modulating Epithelial to Mesenchymal Transition..J Cancer.2020.11(6).1486-1494.SCI |
14. Lin H, Ma N, Zhao L, Yang G, Cao B*.. KDM5c Promotes Colon Cancer Cell Proliferation Through the FBXW7-c-Jun Regulatory Axis..Front Oncol. .2020.16;10:.535449..SCI |
15. Lian X, Zhu C, Lin H, Gao Z, Li G, Zhang N, Cao Bangwei*, Kang Y..Radiosensitization of HER2-positive esophageal cancer cells by pyrotinib..Biosci Rep..2020.40(2).pii: BSR20194167.SCI |
16. Wang B, Ma N, Zheng X, Li X, Ma X, Hu J, Cao B*. . DF15 Repression Contributes to 5-Fluorouracil Resistance in Human Colon Cancer by Regulating Epithelial- Mesenchymal Transition and Apoptosis. .Biomed Res Int..2020.28;2020:.2826010..SCI |
17. Zhao L, Yu J, Wang J, Li H, Che J, Cao Bangwei*.Risk of immune-related diarrhea with PD-1/PD-L1 inhibitors in different cancer types and treatment regimens..J Cancer.2020.11(1).41-50..SCI |
18. Zheng X, Ma N, Wang X, Hu J, Ma X, Wang J, Cao B*. .Exosomes derived from 5-fluorouracil-resistant colon cancer cells are enriched in GDF15 and can promote angiogenesis. . J Cancer..2020.11(24):.7116-7126.SCI |
19. Tian R, Jiang H, Shao L, Yu Y, Guo Q, Cao B*, Guo S.miR193b Promotes Apoptosis of Gastric Cancer Cells via Directly Mediating the Akt Pathway..Biomed Res Int. .2020.25;2020:.2863236.SCI |
20. Gao Z, Song C, Li G, Lin H, Lian X, Zhang N, Cao Bangwei*.Pyrotinib treatment on HER2-positive gastric cancer cells promotes the released exosomes to enhance endothelial cell progression, which can be counteracted by apatinib..Onco Targets Ther.2019.11(12).2777-2787.SCI |
21. Li T, Yu J, Luo X, Ren W, Zhang Y, Cao Bangwei*.VEGFR-2 as a novel predictor of survival in gastric cancer: A systematic review and meta-analysis
.Pathol Res Pract.2018.214(4).560-564.SCI |
22. Lin H, Wang B, Yu J, Wang J, Li Q, Cao Bangwei*.Protein arginine methyltransferase 8 gene enhances the colon cancer stem cell (CSC) function by upregulating the pluripotency transcription factor..J Cancer .2018.9(8).1394-1402.SCI |
23. Li G, Lin H, Tian R, Zhao P, Huang Y, Pang X, Zhao L, Cao Bangwei*. .VEGFR-2 Inhibitor Apatinib Hinders Endothelial Cells Progression Triggered by Irradiated Gastric Cancer Cells-derived Exosomes. .J Cancer.2018.9(21).4049-4057.SCI |
24. Wu J, Yu J, Wang J, Zhang C, Shang K, Yao X, Cao Bangwei*.Astragalus polysaccharide enhanced antitumor effects of Apatinib in gastric cancer AGS cells by inhibiting AKT signalling pathway.Biomed Pharmacother.2018.100.176-183.SCI |
25. Che J, Yue D, Zhang B, Zhang H, Huo Y, Gao L, Zhen H, Yang Y, Cao Bangwei*.Claudin-3 Inhibits Lung Squamous Cell Carcinoma Cell Epithelial-mesenchymal Transition and Invasion via Suppression of the Wnt/β-catenin Signaling Pathway.Int J Med Sci.2018.15(4).339-351.SCI |
26. Li G, Lin H, Tian R, Zhao P, Huang Y, Pang X, Zhao L, Cao Bangwei*.VEGFR-2 Inhibitor Apatinib Hinders Endothelial Cells Progression Triggered by Irradiated Gastric Cancer Cells-derived Exosomes. .J Cancer..2018.9(21).4049-4057.SCI |
27. Li X, Xu A, Li H, Zhang B, Cao Bangwei*, Huang J*.Novel role of apatinib as a multi-target RTK inhibitor in the direct suppression of hepatocellular carcinoma cells..Biochim Biophys Acta.2018.1864(5 Pt A).1693-1701.SCI |
28. Li H, Fan Y, Yang F, Zhao L, Cao Bangwei*.The coordinated effects of Apatinib and Tripterine on the proliferation, invasiveness and apoptosis of human hepatoma Hep3B cells. .Oncol Lett..2018.16(1).353-361.SCI |
29. Lin H, Yang G, Yu J, Wang J, Li Q, Guo S*, Cao Bangwei*. .KDM5c inhibits multidrug resistance of colon cancer cell line by down-regulating ABCC1. .Biomed Pharmacother.2018.107.1205-1209.SCI |
30. Lin H, Wang B, Yu J, Wang J, Li Q, Cao Bangwei*..Protein arginine methyltransferase 8 gene enhances the colon cancer stem cell (CSC) function by upregulating the pluripotency transcription factor..J Cancer.2018.9(8).1394-1402..SCI |
31. Li Q, Li L, Jiang X, Du Q, Li Y, Li T, Gong H, Cao Bangwei*.Characteristics and prognostic values of traditional pathological parameters and advanced molecular subtypes in women in Beijing with operable breast cancer: a retrospective analysis. .BMJ Open.2018.8(11).e021819.SCI |
32. Wu J, Wang J, Su Q, Ding W, Li T, Yu J, Cao Bangwei*.Traditional Chinese medicine Astragalus polysaccharide enhanced antitumor effects of the angiogenesis inhibitor apatinib in pancreatic cancer cells on proliferation, invasiveness, and apoptosis. .Onco Targets Ther.2018.11.2685-2698.SCI |
33. Geng F, Wang Z, Yin H, Yu J,Cao Bangwei*.Molecular Targeted Drugs and Treatment of Colorectal Cancer: Recent Progress and Future Perspectives.Cancer Biother Radiopharm.2017.32(5).149-160.SCI |
34. Zhao L, Leung LH, Wang J, Li H, Che J, Liu L, Yao X, Cao Bangwei*.Association between Charlson comorbidity index score and outcome in patients with stage IIIB-IV non-small cell lung cancer.BMC Pulm Med.2017.17(1).112.SCI |
35. Zhao L, Yu J, Wang J, Li H, Che J,Cao Bangwei*.Isolation and Identification of miRNAs in exosomes derived from serum of colon cancer patients.J Cancer.2017.8(7).1145-1152.SCI |
36. Wang J, Zhao L, Yan H, Che J, Huihui L, Jun W, Liu B, Cao Bangwei*..A Meta-Analysis and Systematic Review on the Association between Human Papillomavirus (Types 16 and 18) Infection and Esophageal Cancer Worldwide..PLoS One.2016.11(7).e0159140.SCI |
37. Li Q, Zhang L, Li X, Yan H, Yang L, Li Y, Li T, Wang J, Cao Bangwei*..The prognostic significance of human epidermal growth factor receptor family protein expression in operable pancreatic cancer : HER1-4 protein expression and prognosis in pancreatic cancer..BMC Cancer..2016.21;16(1).910.SCI |
38. Zhao L, Wang J, Li H, Che J,Cao Bangwei*..Meta-analysis comparing maintenance strategies with continuous therapy and complete chemotherapy-free interval strategies in the treatment of metastatic colorectal cancer..Oncotarget.2016.7(22).33418-28.SCI |
39. Yu J, Che J, Liu L, Yang F, Zhu X, Cao Bnagwei*..Tetrahydropalmatine attenuates irradiation induced lung injuries in rats..Life Sci..2016.3205(16).30202-8.SCI |
40. Yan H, Li Q, Wang W, Zhen H, Cao Bangwei*.Systems assessment of intercalated combination of chemotherapy and EGFR TKIs versus chemotherapy or EGFR TKIs alone in advanced NSCLC patients.Sci Rep.2015.(5)15355.15355.SCI |
41. Zhao L, Liu W, Xiao J, Cao Bangwei*.The role of exosomes and "exosomal shuttle microRNA" in tumorigenesis and drug resistance..Cancer Lett..2015. 28;356(2PtB).339-346.SCI |
42. Ma YJ, Yu J, Xiao J, Cao Bangwei*.The consumption of omega-3 polyunsaturated Fatty acids improves clinical outcomes and prognosis in pancreatic cancer patients: a systematic evaluation.Nutr Cancer..2015.67(1).112-118 .SCI |
43. Li H, Zhen H, Han L, Yan B, Yu J, Zhu S, Cao Bangwei*.Association between the genetic variations within TBX21 gene promoter and the clinicopathological characteristics of esophageal squamous cell carcinoma in a high-risk Chinese population..Tumour Biol.2015.36(5).3985-93.SCI |
44. Yan H, Li H, Li Q, Zhao P, Wang W, Cao Bangwei*.The Efficacy of Synchronous Combination of Chemotherapy and EGFR TKIs for the First-Line Treatment of NSCLC: A Systematic Analysis.PLoS One.2015.10(8).e0135829.SCI |
45. Yu J, Xiao J, Yang Y, Cao Bangwei*.Oxaliplatin-Based Doublets Versus Cisplatin or Carboplatin-Based Doublets in the First-Line Treatment of Advanced Nonsmall Cell Lung Cancer.Medicine (Baltimore).2015.94(27).e1072.SCI |
46. Li Q, Yan H, Zhao P, Yang Y, Cao Bangwei*.Efficacy and Safety of Bevacizumab Combined with Chemotherapy for Managing Metastatic Breast Cancer: A Meta-Analysis of Randomized Controlled Trials.Sci Rep.2015.(5)15746.15746.SCI |
47. Che J, Yang Y, Xiao J, Zhao P, Yan B, Dong S, Cao Bangwei*.Decreased expression of claudin-3 is associated with a poor prognosis and EMT in completely resected squamous cell lung carcinoma.Tumour Biol.2015.36(8).6559-68.SCI |
48. Li Q, Yan H, Liu W, Zhen H, Yang Y, Cao Bangwei*.Efficacy and safety of gemcitabine-Fluorouracil combination therapy in the management of advanced pancreatic cancer: a meta-analysis of randomized controlled trials.PLoS One. .2014.9(8).e104346.SCI |
49. Song L, Ma N, Han L, Yan H, Yan B, Yuan Z, Cao Bangwei*.Association between LMP2/LMP7 genetic variability and the metastasis risk of ovarian cancer in Chinese women in Beijing..Hum Immunol..2014.75(3).239-44.SCI |
50. Li Q, Yuan Z, Yan H, Wen Z, Zhang R, Cao Bangwei*.Comparison of gemcitabine combined with targeted agent therapy versus gemcitabine monotherapy in the management of advanced pancreatic cancer.Clin Ther..2014.36(7).1054-1063.SCI |
51. Li Q, Yuan Z, Cao Bangwei.*.The function of human epidermal growth factor receptor-3 and its role in tumors (Review).Oncol Rep.2013.30(6).2563-70.SCI |
52. Yu J, Zhu X, Qi X, Che J, Cao Bangwei*.Paeoniflorin protects human EA.hy926 endothelial cells against gamma-radiation induced oxidative injury by activating the NF-E2-related factor 2/heme oxygenase-1 pathway..Toxicology letters.2013.218(3).224-234.SCI |
53. Cao Bangwei, Dong S, Su Q, Yan B, Zhen H, Yuan Z, Liu X, Li Y..Lack of association between the unique LMP2 gene polymorphism and the outcome of lung cancer in a population of Chinese Han nationality. .Human immunology.2012.73 (5).580–584.SCI |
54. Cao Bangwei, Zhu L, Zhu S, Li D, Zhang C, Xu C, Zhang S.Genetic variations and haplotypes in TIM-3 gene and the risk of gastric cancer.Cancer Immunol Immunother.2010.59(12).1851-1857.SCI |
55. Hou R, Cao Bangwei#, Chen Z, Li Y, Ning T, Li C, Xu C, Chen Z*.Association of cytotoxic T lymphocyte-associated antigen-4 gene haplotype with the susceptibility to gastric cancer.Molecular biology reports.2010.37(1).515-520.SCI |
56. Cao Bangwei, Liu X, Hou F, Li W, Han Z, Zhang Q, Dai Y, Xu C, Qi H*.The haplotype of the MxA gene promoter is associated with hepatitis B virus infection in a Chinese population.Liver International.2009.29(9).1383-1388.SCI |
57. Xu C, Qi S, Gao L, Cui H, Liu M, Yang H, Li K, Cao Bangwei*.Genetic polymorphisms of LMP/TAP gene and hepatitis B virus infection risk in the Chinese population.Journal of Clinical Immunology.2007.27(5).534-541.SCI |
58. Cao Bangwei, Yang H, Ding H, Qi S, Gao L, Cui H, Dai Y, Xu C*.Association analysis of hepatitis virus B infection with haplotypes of the TBX21 gene promoter region in the Chinese population.Clinical Chemistry and Laboratory Medicine .2007.45(3).333-338.SCI |
59. Liu M, Cao Bangwei#, Zhang H, Dai Y, Liu X, Xu C*.Association of interferon-gamma gene haplotype in the Chinese population with hepatitis B virus infection.Immunogenetics.2006.58(11).859-864.SCI |
60. Qi S, Cao Bangwei#, Jiang M, Xu C, Dai Y, Li K, Wang K, Ke Y, Ning T*.Association of the -183 polymorphism in the IFN- gene promoter with hepatitis B virus infection in the Chinese population.Journal of Clinical Laboratory Analysis.2005.19(6).276-281.SCI |
61. Cao Bangwei, Tian X, Li Y, Jiang P, Ning T, Xing H, Zhao Y, Zhang C, Shi X, Chen D, Shen Y, Ke*.LMP7/TAP2 gene polymorphisms and HPV infection in esophageal carcinoma patients from a high incidence area in China.Carcinogenesis.2005.26(7).1280-1284.SCI |